亚催眠剂量丙泊酚减少剖宫产术中恶心呕吐的随机对照研究

目的研究亚催眠剂量丙泊酚对剖宫产产妇术中恶心呕吐的作用。方法64例腰麻硬膜外联合麻醉下剖宫产患者随机分成对照组（A组）和丙泊酚组（B组）,在脐带结扎后至缝皮结束按照血浆靶控浓度1 μg/mL靶控丙泊酚,A组以脂肪乳代替丙泊酚。比较2组镇静深度、恶心呕吐程度、镇吐药剂量、升压药剂量、脉搏氧饱和度、术者及患者满意度、新生儿神经行为学评分(neonatal behavioral neurological assessment,NBNA)等。结果A组恶心呕吐发生率明显高于B组,差异有统计学意义（P＜0.05）;在脐带结扎后的10 min 2组镇静深度评分比较差异无统计学意义(P>0.05),20、30 min 2组比较差异有统计学意义（P＜0.05）;2组术中应用升压药物次数、血氧饱和度比较差异无统计学意义(P>0.05);术者与患者的满意度,B组与A组比较差异有统计学意义（P＜0.05）;2组新生儿Apgar评分及母乳喂养后2组新生儿NBNA比较差异无统计学意义(P>0.05)。结论亚催眠剂量丙泊酚(1 μg/mL)可有效降低剖宫产术中恶心呕吐发生率,术中呼吸循环稳定,且不影响术后母乳喂养。     

昂丹司琼预防和治疗腹腔镜胆囊切除术后恶心呕吐的疗效观察

目的：观察并分析昂丹司琼预防和治疗腹腔镜胆囊切除术后恶心、呕吐反应的临床效果。方法86例慢性结石性胆囊炎患者在全麻下接受常规腹腔镜胆囊切除术。将其分为术前用药组36例、术后用药组25例和对照组25例。术前用药组于麻醉前30分钟通过静脉注射盐酸昂丹司琼8 mg、术后用药组麻醉清醒后立即给予静脉注射盐酸昂丹司琼8 mg,对照组不给予任何止吐药物。观察至术后48小时,统计各组中恶心、呕吐反应的发生例数和药物不良反应情况。结果86例患者共有25例发生恶心、呕吐反应。术前用药组、术后用药组和对照组的恶心、呕吐发生率分别为27.8%、12.0%和48.0%。术后用药组与对照组相比有统计学意义（χ^2=7.71,P＜0.05）,说明术后用药可减少术后恶心、呕吐的发生;术前用药组与对照组比较无统计学意义（χ^2=2.61,P＞0.05）,说明术前用药不能预防术后恶心、呕吐的发生。25例患者术后发生恶心、呕吐,给予经静脉注射盐酸昂丹司琼8 mg,有21例患者缓解,缓解率为84.0%,用药过程中未发生药物不良反应。结论盐酸昂丹司琼预防和治疗LC术后恶心、呕吐是安全、有效的,预防性用药最佳时机应该为麻醉清醒时。     

不同剂量盐酸格拉司琼预防术后病人自控镇痛恶心呕吐的临床观察

目的比较不同剂量盐酸格拉司琼预防术后病人自控镇痛(PCA)恶心呕吐的临床疗效。方法150例患者随机分为三组,观察并比较术后48h内病人的镇痛效果和恶心呕吐的发生情况。结果盐酸格拉司琼可显著减少术后呕吐的发生率,6mg与9mg组病人术后恶心、呕吐的发生率无显著性差异(P>0.05),与对照组比较差异有显著性(P<0.05)。结论全麻腹部手术后采用PCA者使用盐酸格拉司琼可显著减少术后恶心呕吐的发生率。     

瑞芬太尼-丙泊酚静脉麻醉用于无痛胃镜检查术的疗效观察

目的为探讨安全、有效九痛胃镜检查术的药物选择和剂量,选用最新的μ阿片受体激动药瑞芬太尼和短效静脉麻醉药丙泊酚组合,采用对照的方法．观察其临床疗效。方法200例接受无痛胃镜检查术的患者,静脉麻醉药按公斤体重用药配制,分成4组,Ⅰ组丙泊酚（即得普利麻,下同）2mg／kgiv;Ⅱ组芬太尼1μg／kg＋丙泊酚2mg／kg iv;Ⅲ组瑞芬太尼0．5μg／kg＋丙泊酚1.5mg／kiv;Ⅳ组瑞芬太尼0．75μg／kg＋丙泊酚1mg／kg iv。观察指标：起故时间,麻醉深度,术中HR、R和SpO2的变化,有尤呛咳、喉痉挛等副作用,术毕清醒时间和离院时间,以及术后有九恶心、呕吐等并发症。结果Ⅳ组与其他各组比较,起效时间,清醒时间,离院时间,麻醉深度,术中呼吸抑制等指标均有显著差异（P〈0．01）。结论选用瑞芬太尼0.75μg／kg与丙泊酚1mg／kg复合的静脉麻醉配方用于胃镜检查起效快,清醒快．麻醉深度合适,术巾、术后副作用少,适用于胃镜检查,只要注意预防药物的副作用,是一种安全、有效、可控性强的麻醉方法。     

人工流产术中两种镇痛方法的临床疗效观察

目的观察丙泊酚联合芬太尼、阿托品全麻无痛人流与利多卡因联合芬太尼、阿托品清醒无痛人流两种方法临床效果。方法将孕6-10周需要终止妊娠并要求无痛人流孕妇400例随机分为两组,每组200例,Ⅰ组采用丙泊酚联合芬太尼、阿托品静脉全麻无痛人流,Ⅱ组采用2%利多卡因联合芬太尼、阿托品宫颈注射清醒无痛人流,观察两组术中镇痛、麻醉监测及出血量、人流综合征发生率并进行比较。结果丙泊酚组镇痛效果优于利多卡因组,而利多卡因组在操作方面及麻醉安全性上优于丙泊酚组。结论两种方法均值得临床推广应用。     

双侧胸椎旁神经阻滞对肺癌根治术患者术后镇痛效果影响

目的探讨全麻复合双侧胸椎旁神经阻滞(TVPB)对肺癌根治术患者术后镇痛效果的影响。方法选取择期拟在全身麻醉下行肺癌根治术的患者60例作为研究对象。采用随机数字表法,将患者随机分为单纯全麻组(G组)和双侧胸椎旁神经阻滞复合全麻组(GP组),每组30例。两组患者均选择静脉麻醉诱导气管插管,麻醉维持采用静脉吸入复合麻醉。GP组于麻醉诱导前在神经刺激器引导下行双侧T4~T5椎旁神经阻滞,两侧分别给予0.5%罗哌卡因15 ml,G组不给予上述处理。术毕,两组患者均使用舒芬太尼自控静脉镇痛,维持视觉模拟评分(VAS)≤3分,当VAS评分>3分时,则静脉给予吗啡。分别于术后2、6、12、24、48 h行布氏舒适度评分(BCS),记录患者术后24 h舒芬太尼用量、患者自控静脉(PCIA)泵按压次数、吗啡用量,并观察患者术后不良反应(恶心、呕吐、嗜睡、皮肤瘙痒及呼吸抑制)的发生情况。结果与G组比较,GP组患者术后各时点BCS舒适度评分均升高,术后24 h舒芬太尼用量、PCIA泵按压次数及吗啡用量均减少(P<0.05)。G组患者术后出现恶心12例,呕吐8例,嗜睡5例,皮肤瘙痒2例,未出现呼吸抑制;GP组患者术后出现恶心6例,呕吐3例,未出现嗜睡、皮肤瘙痒及呼吸抑制。结论与单纯全麻比较,术前行双侧胸椎旁神经阻滞复合全麻用于肺癌根治术患者术后镇痛效果更佳,并可降低术后不良反应的发生率。     

快通道麻醉在ASAⅡ～Ⅲ级老年患者麻醉中的应用

目的探讨瑞芬太尼联合丙泊酚双通道靶控输注全凭静脉麻醉与静吸复合全麻在ASAⅡ～Ⅲ级老年患者全身麻醉中的应用。方法择期手术50例,年龄62～89岁,ASAⅡ～Ⅲ级,手术时间1～3h。随机分为2组,瑞芬太尼-丙泊酚靶控输注组（TCⅠ组）和静吸复合全麻组（Ⅰ组）,每组25例。分别采用全凭静脉和静吸复合维持麻醉,观察术毕停药后患者自主呼吸恢复的时间、睁眼时间、拔管时间、离开手术间的时间,并观察术后是否有恶心、呕吐、呼吸抑制、术后躁动、肌肉僵直等不良反应。结果TCI组患者较Ⅰ组术毕停药后自主呼吸恢复的时间、睁眼时间、拔管时间、离开手术间的时间均早,并且术后不良反应低。结论与静吸复合全麻相比,在ASAⅡ～Ⅲ级老年患者全身麻醉中应用瑞芬太尼联合丙泊酚双通道靶控输注全凭静脉麻醉,患者血流动力学更平稳,术后苏醒快,不良反应少,麻醉效果及安全性好,值得推广。     

罗哌卡因骶管阻滞对丙泊酚无痛人流的临床效果观察

目的观察不同浓度罗派卡因复合芬太尼骶管阻滞对丙泊酚无痛人工流产术麻醉效果及术后下腹痛等并发症的影响。方法160例早孕妇女，随机分为4组，全麻组和复合1、2、3组，每组40例。全麻组实施单纯丙泊酚全身麻醉，复合组1、2、3组分别用0．075％、0．15％、0．3％罗派卡因和芬太尼（2ug／m1）行改良骶管阻滞麻醉，再行丙泊酚全身麻醉。结果四组病人丙泊酚诱导用量无显著性差异（P〉0．05），复合2组和3组麻醉效果明显优于全麻组，P〈0．05，术后下腹痛发生率和程度明显小于全麻组，P〈0．05，恶心呕吐，唾液增多及皮肤瘙瘁病例各复合组明显少于全麻组，P〈0．05。结论0．15％罗哌卡因复合芬太尼骶管阻滞可改善丙泊酚用于人工流产术的麻醉效果，减少丙泊酚的用量，减轻术后下腹痛等并发症，对下肢运动无影响。     

丙泊酚复合芬太尼静脉全麻辅助电子胃镜下置入食管支架的临床观察

目的：探讨丙泊酚复合芬太尼静脉全麻辅助电子胃镜下置入食管支架效果。方法：对36例置入食管支架的患者进行回顾性分析。结果：麻醉效果满意，对操作过程无记忆，无疼痛感及恶心、呕吐。手术一次性成功率100％。结论：丙泊酚复合芬太尼静脉全麻辅助电子胃镜下置入食管支架可减少操作时间，提高成功率。     

全麻和全麻复合硬膜外阻滞在食管癌根治术中的效果比较

目的比较食管癌根治术患者采用全麻及全麻复合硬膜外阻滞的麻醉效果。方法收集来我院进行治疗的71例食管癌患者。随机分为全麻组36例,全麻复合硬膜外阻滞组35例,对两组患者的手术情况、术中麻醉维持用药量、围术期各时间点MAP和HR、两组患者术毕至清醒时各项指标进行比较。结果全麻与复合硬膜外阻滞组比较,全麻组具有较高的异氟醚、阿曲库铵、丙泊酚的用量,两组间的差异具有显著性（P〈0．05）。在诱导后、切皮、病灶切除MAP及心率两组比较差异具有显著性（P〈0．05）。与全麻组比较,全麻复合硬膜外阻滞组的吞咽反射、SPO2〉90％、拔除气管导管、睁眼实验阳性、完全清醒的时间经统计学分析差异均具有显著性（P〈0．05）。结论食管癌患者采用全麻复合硬膜外阻滞进行手术能够降低药物的用量．减少患者的术后躁动．具有更为稳定的血流动力学。     

Propofol and propofol glucuronide concentrations in hair following medical propofol administration and in forensic death cases

Purpose

Propofol is the most preferred drug for general anesthesia as well as for analgosedation. However, the rate of abuse cases has increased in the past decade. Hair analysis is considered as the method of choice to determine chronic drug use, and propofol and propofol glucuronide have already been used to confirm previous propofol administration. However, given its frequent medical use, it is important that nonmedical propofol abuse can be distinguished from medical propofol application.

Methods

Nineteen hair samples collected from living subjects who received different doses of propofol in the setting of medical treatment and 31 hair samples from forensic death cases with indications of previous propofol administration were examined using our previously described method enabling the simultaneous extraction of propofol and propofol glucuronide from hair followed by validated liquid chromatography–tandem mass spectrometry analyses.

Results

Recent propofol administration was verified for eight of 19 living cases and 29 of 31 deceased cases. Of the living cases, propofol glucuronide could be detected in all eight cases, whereas propofol could only be detected in three of these cases. Propofol glucuronide could be detected more frequently and in higher concentrations than propofol following medical propofol administration and observed concentrations varied more widely.

Conclusions

Although further research is still required to clarify the mechanisms involved in propofol incorporation into hair and to establish reliable cutoff concentrations for the differentiation of medical from nonmedical propofol use, it seems likely that relatively high concentrations of propofol found across multiple hair segments strongly suggest a nonmedical propofol abuse.

     

Hematological, anthropometric, and metabolic comparisons between vegetarian and nonvegetarian elderly women

The purpose of this study was to investigate hematological, anthropometric, and metabolic differences in elderly women who were similar in most respects except for choice of diet. Nineteen vegetarian (V) and 12 non-vegetarian (NV) elderly women (mean ages 72.3 +/- 1.4 and 69.5 +/- 1.0 years, respectively) were recruited based on several selection criteria including race, religion, education, Quetelet Index, absence of major chronic disease and use of medications, physical activity, and geographic area. Average years of adherence by V and NV groups to dietary regimens were 46.3 +/- 3.3 and 69.6 +/- 1.0, respectively; Hematological comparisons revealed that the V elderly women had significantly lower glucose (4.60 +/- 0.09 vs 5.13 +/- 0.11 mmol/L), low-density lipoprotein cholesterol (3.14 +/- 0.19 vs 4.09 +/- 0.27 mmol/L) and total cholesterol levels (5.41 +/- 0.20 vs 6.48 +/- 0.29 mmol/L) than the NV elderly women (P less than 0.01) for each. The V elderly women tended to have less body fat and midupper arm muscle area than the NV. No differences between groups were found in a variety of metabolic and electrocardiographic parameters during graded maximal treadmill testing except for lower heart rates in the V women. VO2max was not significantly different between the V and NV elderly women (23.8 +/- 1.5 vs 21.9 +/- 0.8 ml.kg-1.min-1, respectively). In summary, when healthy elderly V women are compared with closely matched NV peers, the vegetarian diet is associated with several benefits, primarily lower blood glucose and lipid levels, but not greater functional capacity.     

纳洛酮与舒芬太尼混合输注在老年患者胃食管反流病射频手术的应用

目的 评价纳洛酮与舒芬太尼混合液在老年患者胃食管反流病射频手术的麻醉效果。方法 择期行胃镜下射频治疗的老年患者（年龄≥65）120例随机分为对照组（舒芬太尼复合丙泊酚麻醉)和干预组（舒芬太尼纳洛酮混合液复合丙泊酚麻醉)。记录术中平均血压较基线值波动大于20%的例数、平均动脉压和心率、BIS值;记录苏醒时间、丙泊酚用量和术后1 h痛觉(Visual Analogue Score,VAS)评分等。结果 对照组（26例,43%）血压波动大于20%的例数大于干预组（10例,17%）（P=0.001）;干预组BIS值高于对照组（P<0.01）;干预组丙泊酚的用量小于对照组用量（P<0.01）,干预组苏醒时间短于对照组（P<0.01）,干预组术后1 h VAS评分低于对照组（P=0.005）。结论 纳洛酮舒芬太尼混合输注镇痛效果增强,可使丙泊酚用量减少,血流动力学更稳定,苏醒时间缩短。     

Importance of an automatic measurement base on the first coil diameter in regard to coil embolization of a cerebral aneurysm

We compared the accuracy in evaluating an unrapture aneurysm between NV and 3D-DSA. In vitro, we evaluated the accuracy in calculating the volume of the Aneurysm model. We compared the diameter of the first coil and estimated the diameter of the Aneurysm. The Aneurysm size calculated by NV resembled the first coil more than the size measured by 3D-DSA. In clinical cases, the measurement of NV is objective; the measurement of 3D-DSA, however, is subjective by person. NV has an automatic measurement that is useful for clinical cases.     

喷他佐辛减轻甲状腺癌手术应激反应的临床研究

目的：探讨喷他佐辛联合丙泊酚能否通过抑制诱导性一氧化氮合酶（ iNOS）减轻甲状腺癌手术患者应激反应。方法随机将100例甲状腺癌手术患者分为对照组和干预组,麻醉维持分别静脉给予丙泊酚和喷他佐辛联合丙泊酚。分别测定两组麻醉前、麻醉1 h 及手术结束后的心率（ HR）、平均动脉压（ MAP）、收缩压（ SBP）和舒张压（ DBP）水平,以及血MDA水平和SOD活性。同时使用RT-PCR法测定麻醉前和麻醉1 h时患者血iNOS mRNA的表达水平。结果在麻醉1 h和手术结束后,两组HR、MAP、SBP和DBP均较麻醉前明显升高（ P﹤0.05）,而对照组比干预组升高更显著（ P﹤0.05）;在麻醉1 h和手术结束后,两组血MDA水平较麻醉前升高,血SOD活性下降（P﹤0.05）,但与干预组相比较,对照组改变更显著（P﹤0.05）;在麻醉1 h,两组血iNOS mRNA的表达水平较麻醉前明显升高（ P﹤0.05）,但对照组比干预组升高更明显（ P﹤0.05）。结论喷他佐辛联合丙泊酚进行麻醉,可能是通过抑制iNOS 改善了甲状腺癌手术患者应激反应水平。     

舒芬太尼与地佐辛用于无痛胃镜检查麻醉的临床效果

 目的 比较舒芬太尼和地佐辛应用于无痛胃镜检查麻醉的临床效果。方法 根据不同麻醉方案,采用随机数字表法将180例门诊行无痛胃镜患者随机分为3组,A组(舒芬太尼组):舒芬太尼0.1 μg/kg+丙泊酚;B组(地佐辛组):地佐辛70 μg/kg+丙泊酚;C组(对照组):生理盐水+丙泊酚。观察并记录3组患者注药至睫毛反射消失时间,胃镜检查时间,丙泊酚总用量,麻醉前后MAP、HR、SPO₂,术中呼吸暂停次数及麻醉苏醒期恶心、呕吐、头晕不良反应发生率。结果 注药至睫毛反射消失时间A组(90.3±8.2) s、B组(95.3±9.1)s和C组(125.7±7.3)s比较,A组时间明显缩短,差异有统计学意义(P<0.05);丙泊酚用量A组(63.1±9.2)mg、B组(70.4±5.9)mg和C组(89.3±6.4)mg比较,用药量明显减少,差异有统计学意义(P<0.05);B组麻醉苏醒期恶心、头晕发生率(20.0%;21.7%)较A组(1.7%;8.3%)和C组(0.0%;1.7%)明显增高,差异有统计学意义(P<0.05)。结论 舒芬太尼联合丙泊酚用于无痛胃镜检查麻醉效果更好,不良反应发生率更低,是无痛胃镜治疗安全有效的麻醉方案。     

Propofol infusion syndrome

In this article, we present the case of a previously well 31-year-old man who sustained a mild closed-head injury following a motor vehicle incident and was admitted to the intensive care unit of a major teaching hospital. The man was sedated using propofol combined with midazolam and morphine as the main sedating agent. The propofol was started and continued at high dose for 8 days, over which time the patient deteriorated with metabolic acidosis, rhabdomyolysis, renal impairment, and cardiovascular collapse and then died. A forensic autopsy was performed. The only positive autopsy finding was a cardiac perivascular and interstitial infiltrate of mononuclear cells. The clinical and pathological features in the case presented were consistent with propofol infusion syndrome. No other cause for the above features was found and the cause of death was given as death related to propofol infusion syndrome. Propofol infusion syndrome is characterized by metabolic acidosis, rhadbomyolysis, and myocardial failure, sometimes with renal failure and hyperkalemia occurring in the setting of high-dose propofol treatment. The syndrome has become increasingly recognized in recent years. The syndrome is of importance to forensic pathologists who may see cases referred to their practice because of the unexplained deterioration of a patient in the intensive care unit and the association with head-injured patients and the pediatric population. Death associated with propofol infusion has not been described in the forensic literature.     

细胞因子及异丙酚对中性粒细胞内caspase-3活性的影响

 目的观察细胞因子白介素-6(IL-6)和白介素-10(IL-10)及异丙酚对离体的健康人中性粒细胞内caspase-3活性的影响,了解细胞因子及异丙酚影响中性粒细胞凋亡的机制.方法选择12例健康志愿者,采静脉血并分离中性粒细胞,将每例分离的中性粒细胞分为8组,分别加入生理盐水(对照组)、IL-6、IL-10、IL-6+IL-10、异丙酚、异丙酚的脂质溶剂intralipid、IL-6+异丙酚、IL-6+intralipid孵育,18 h后利用专用的试剂盒用流式细胞仪检测每个样本caspase-3激活的程度,并进行组间比较.结果与对照组相比,IL-6显著抑制中性粒细胞caspase-3的激活(P＜0.05),而IL-10、异丙酚和intralipid对caspase-3的激活则无显著影响;但IL-10和异丙酚均能够对抗IL-6对caspase-3激活的抑制(P＜0.05),intralipid则未表现对抗IL-6的作用.结论IL-6可抑制中性粒细胞内caspase-3的激活,而IL-10和异丙酚可对抗IL-6的这一作用,提示IL-6、IL-10和异丙酚对中性粒细胞凋亡的影响至少部分是通过影响caspase-3的激活来实现的.     

Functional results of exclusive interventional radiotherapy (brachytherapy) in the treatment of nasal vestibule carcinomas

PurposeSurgery, external beam radiotherapy (EBRT), and interventional radiotherapy (IRT, BrachyTherapy BT) are the current therapeutic options for nose vestibule (NV) squamous cell carcinoma (SCC). In this article, we evaluate the nose functional parameters of patients affected by SCCs of the NV, primarily treated by interstitial IRT comparing them with healthy controls and with patients treated with intensity-modulated EBRT.MethodsTen patients treated by using IRT (group 1), 10 healthy controls and eight patients treated by EBRT (group 2) on the region of the nose were submitted to clinical evaluation (with the NOSE scale score), rhinomanometry, olfactory testing, nasal citology, and evaluation of mucociliary clearance through saccharine test.ResultsNo long-term skin or cartilaginous toxicity are recorded. The olfactometry threshold discrimination identification TDI is lower in EB group. The mean NOSE scale score was significantly higher in group 2 than in group 1 and healthy controls (p < 0.05). The distribution of cytologic patterns resulted significantly different as well. Patients treated by EB have a significantly impaired mucociliary clearance, with a mean time for the transport of the stained marker, which is more than double in the patients treated by EB than in those treated with IRT (p < 0.001).ConclusionsNasal function and cytological findings are significantly better, substantially preserved, in patients treated by IRT than in those treated by EBRT, bringing new relevant evidence for the establishment of interstitial IRT as the new standard for the treatment of the primary lesion in cT1 and cT2 -Wang staging NV SCCs.     

快速康复外科理念结合七氟醚、异丙酚全麻对老年乳腺癌术后苏醒时间及认知功能的影响

 目的 探讨快速康复外科理念(fast track surgery,FTS) 结合七氟醚、异丙酚全麻对老年乳腺癌术后苏醒时间及认知功能的影响。方法 选择我院收治的62例老年乳腺癌患者,随机分为七氟醚组和丙泊酚组(每组31例)。术前麻醉中,两组患者均行依托咪酯、芬太尼、维库溴铵、咪达唑仑诱导麻醉,其中七氟醚组患者予以七氟醚维持麻醉,丙泊酚组患者予以异丙酚维持麻醉。评价两组患者的麻醉效果;统计患者恢复自主呼吸时间、睁眼时间、定向力恢复时间及Aldrete评分;同时采用简易智能精神状态评分(MMSE评分)评估患者术后认知功能障碍的发生率。结果 观察组和对照组麻醉效果优良率均为100%。平均恢复自主呼吸时间、睁眼时间、定向力恢复时间指标值的比较上,丙泊酚组均短于七氟醚组(P<0.05);在平均 Aldrete评分指标值的比较上,七氟醚组低于丙泊酚组(P<0.05)。术后2 h,两组患者平均MMSE评分较麻醉前均降低(P<0.05),七氟醚组患者认知功能障碍发生率为38.71%,丙泊酚组为19.35%,七氟醚组高于丙泊酚组(P<0.05);术后12 h,七氟醚组患者认知功能障碍发生率为22.58%,丙泊酚组为9.68%,七氟醚组高于丙泊酚组(P<0.05)。结论 七氟醚、异丙酚全麻在老年乳腺癌患者麻醉中能取得相当的麻醉效果,但FTS理念下异丙酚麻醉患者的苏醒质量优于七氟醚,且能减少术后认知功能障碍的发生率,康复效果更好。